The Mitie share price plunges 43% on rights issue! Why I think this is a bargain stock

The Mitie share price has plunged today, but I think its latest acquisition could lead to sustained growth and a brighter future.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

CORRECTION: The original version of this article incorrectly stated that Mitie Group’s earnings per share was 25p and its price-to-earnings ratio less than 2. This error has now been rectified.

The Mitie (LSE:MTO) share price is down 43% today after it diluted its stock with a rights issue. Mitie launched the £201m rights issue last month and announced it would be buying Interserve’s facilities management arm for £271m in cash and shares. Today the rights issue commenced with the admission of 805m new shares. The new shares will help to reduce the debt burden on the group.

Public meets private

Despite the share price fall, this move creates a more even balance in the group between the public and private sector. The business acquisition will increase Mitie’s exposure to the public sector. Services provided by the acquisition include building maintenance, fire safety, waste management, cleaning, catering, front-of-house and security. These will be delivered to a variety of clients including corporate offices, manufacturing plants, schools, hospitals, and defence estates. It should pave the way for Mitie to become a market leader in technical, security and cleaning services. Combining the two businesses will also help consolidate and reduce costs in areas such as IT and administration.

Value in the Mitie share price

I think this price plunge could be creating an opportunity to buy cheap shares in a quality company. The pandemic has created an increased need for hygiene vigilance in companies. Both the public and private sectors must be more thorough than ever in their cleaning practices. Outsourcing is the simplest solution for many such businesses.

Mitie and Interserve are among Britain’s biggest government contractors, and the merger is expected to generate combined revenue of £3.5bn. Mitie has a market capitalisation of £576m. Adjusted earnings per share are approximately 8p generating a price-to-earnings (P/E) ratio of almost 5.

As the pandemic rages on, it is hampering business as usual, but as the group pays down debt and realigns itself as a major player in outsourced services, I think this stock could be a good addition to a long-term investor’s portfolio. The Mitie share price may be subject to continued volatility as the financial markets wrestle with economic uncertainty and geopolitical fallout. But, I think this company has a lot going for it and believe the share price will bounce back and thrive in the years to come.

Investing in healthcare 

Another share I like the look of is medical equipment manufacturer Smith and Nephew (LSE:SN), which specialises in joint implants and surgical robotics. The lockdown has put a pause on many non-essential operations and caused a backlog to build.

Yet while leading an active lifestyle is positively encouraged nowadays, it can contribute to further wear and tear on joints. This leads to surgery. I think a surge in demand for knee and hip replacements will be seen in the coming years, driving up sales for Smith and Nephew.

Valued at £13.4bn, this FTSE 100 healthcare stock has a P/E of 28, its dividend yield is 1.8% and earnings per share are 54p.

Expensive maybe, with an unspectacular dividend yield. But Smith and nephew stands to benefit from the ageing population, increase in demand for joint replacements and advancements in modern surgery. Along with Mitie shares, I think Smith and Nephew is another good addition to a long-term investor’s portfolio.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Kirsteen has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Black woman using loudspeaker to be heard
Investing Articles

I was right about the Barclays share price! Here’s what I think happens next

Jon Smith explains why he still feels the Barclays share price is undervalued and flags up why updates on its…

Read more »

Investing Articles

Where I’d start investing £8,000 in April 2024

Writer Ben McPoland highlights two areas of the stock market that he would target if he were to start investing…

Read more »

View of Tower Bridge in Autumn
Investing Articles

Ahead of the ISA deadline, here are 3 FTSE 100 stocks I’d consider

Jon Smith notes down some FTSE 100 stocks in sectors ranging from property to retail that he thinks could offer…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

Why I think Rolls-Royce shares will pay a dividend in 2024

Stephen Wright thinks Rolls-Royce shares are about to pay a dividend again. But he isn’t convinced this is something investors…

Read more »

Investing Articles

1 of the best UK shares to consider buying in April

Higher gold prices and a falling share price have put this FTSE 250 stock on Stephen Wright's list of UK…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

The market is wrong about this FTSE 250 stock. I’m buying it in April

Stephen Wright thinks investors should look past a 49% decline in earnings per share and consider investing in a FTSE…

Read more »

Black father and two young daughters dancing at home
Investing Articles

1 FTSE 250 stock I own, and 1 I’d love to buy

Our writer explains why she’s eyeing up this FTSE 250 growth phenomenon, and may buy more shares in this property…

Read more »

View of Tower Bridge in Autumn
Investing Articles

The FTSE 100 is closing in on 8,000 points! Here’s what I’m buying before it’s too late!

As the FTSE 100 keeps gaining momentum, this Fool is on the lookout for bargains. Here's one stock he'd willingly…

Read more »